One connector, four scholarly indexes, real DOIs and legal free PDFs. Works in Claude and ChatGPT.
Paste it into Claude or ChatGPT as a custom connector. 3-day free trial.
Mohammed Elmowafy, Mohammad Mahmoud Al-Sanea
NLCs have provoked the incessant impulsion for the development of safe and valuable drug delivery systems owing to their exceptional physicochemical and then biocompatible characteristics. Throughout the earlier period, a lot of studies recounting NLCs based formulations have been noticeably increased. They are binary system which contains both solid and liquid lipids aiming to produce less ordered lipidic core. Their constituents particularly influence the physicochemical properties and effectiveness of the final product. NLCs can be fabricated by different techniques which are classified according to consumed energy. More utilization NLCs is essential due to overcome barriers surrounded by the technological procedure of lipid-based nanocarriers' formulation and increased information of the core mechanisms of their transport via various routes of administration. They can be used in different applications and by different routes such as oral, cutaneous, ocular and pulmonary. This review article seeks to present an overview on the existing situation of the art of NLCs for future clinics through exposition of their applications which shall foster their lucid use. The reported records evidently demonstrate the promise of NLCs for innovate therapeutic applications in the future.
Formatted from the source metadata, not typed by hand. For a whole reference list, use the citation generator or ask your assistant through Find Research.
Elmowafy, M., & Al-Sanea, M. M. (2021). Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies. Saudi Pharmaceutical Journal, 29(9), 999–1012. https://doi.org/10.1016/j.jsps.2021.07.015
Elmowafy, Mohammed, and Mohammad Mahmoud Al-Sanea. "Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies." Saudi Pharmaceutical Journal, vol. 29, no. 9, 2021, pp. 999–1012, https://doi.org/10.1016/j.jsps.2021.07.015.
Elmowafy, Mohammed, and Mohammad Mahmoud Al-Sanea. "Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies." Saudi Pharmaceutical Journal 29, no. 9 (2021): 999–1012. https://doi.org/10.1016/j.jsps.2021.07.015.
Elmowafy M., Al-Sanea M. M. Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies // Saudi Pharmaceutical Journal. — 2021. — Vol. 29, № 9. — P. 999–1012. — URL: https://doi.org/10.1016/j.jsps.2021.07.015
@article{elmowafy2021nanostructured,
title = {{Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies}},
author = {Mohammed Elmowafy and Mohammad Mahmoud Al-Sanea},
journal = {Saudi Pharmaceutical Journal},
year = {2021},
volume = {29},
number = {9},
pages = {999--1012},
doi = {10.1016/j.jsps.2021.07.015},
url = {https://doi.org/10.1016/j.jsps.2021.07.015}
}TY - JOUR AU - Elmowafy, Mohammed AU - Al-Sanea, Mohammad Mahmoud TI - Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies JO - Saudi Pharmaceutical Journal VL - 29 IS - 9 SP - 999 EP - 1012 PY - 2021 DA - 2021/07/21 DO - 10.1016/j.jsps.2021.07.015 UR - https://doi.org/10.1016/j.jsps.2021.07.015 ER -
Add Find Research to Claude or ChatGPT and ask in plain language. The assistant reads this record, finds the papers around it and cites only what it actually found:
Setup takes about a minute: add the connector, then start the free trial.
Record from OpenAlex; open-access location from Unpaywall and the indexes. Find Research links only to legal copies.